Iambic Therapeutics, Inc. (IAM) Ownership Overview
The ownership structure of Iambic Therapeutics, Inc. (IAM) stock is a mix of institutional, retail, and individual investors. , 4.27% is owned by Insiders, and 92.62% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 19, 2026 | xxxxxxxxxxxxx | $11500000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,400,206 | Institution | 2.95% | 20,176,968 | |
| 742,546 | Insider | 1.57% | 10,700,088 | |
| 742,546 | Insider | 1.57% | 10,700,088 | |
| 279,902 | Insider | 0.59% | 4,033,388 | |
| 200,920 | Insider | 0.42% | 2,895,257 | |
| 73,413 | Institution | 0.15% | 1,057,881 | |
| 57,754 | Insider | 0.12% | 832,235 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
FAQ
Who Owns Iambic Therapeutics, Inc. (IAM)?
Currently, no data Available
What percentage of Iambic Therapeutics, Inc. (IAM) stock is held by institutional investors?
Currently, no data Available
What percentage of Iambic Therapeutics, Inc. (IAM) stock is held by retail investors?
According to the latest TipRanks data, approximately 92.62% of Iambic Therapeutics, Inc. (IAM) stock is held by retail investors.
Who owns the most shares of Iambic Therapeutics, Inc. (IAM)?
ARK owns the most shares of Iambic Therapeutics, Inc. (IAM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.